A phase I study of novel multi-HLA-binding peptides and a new combination of immune adjuvants against solid tumors. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback